Add to cart: Online marketplaces join forces to provide researchers instant access to biospecimens

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/opolja)
(Image: Getty/opolja)

Related tags: Scientific method, Science

To simplify the human biospecimens procurement process, the online marketplace for outsourced scientific services, Scientist.com, has teamed up with iSpecimen.

iSpecimen, a Lexington, MA-based company, developed the iSpecimen Marketplace, which allows researchers to search for human specimens online.

The company’s CEO, Christopher Ianelli, MD, PhD, told us the marketplace allows researchers to instantly search for and select human biospecimens for their studies.

As part of the agreement with Scientist.com, the online marketplaces will join forces to offer iSpecimen’s services, including biofluids, solid tissue, and viable cells, on Scientist.com.

The specimens are sourced from the company’s partner network of hospitals, labs, biorepositories, blood centers, and other healthcare institutions.

By partnering with Scientist.com, which brings a suite of scientific services to researchers across the globe, we tap into a ready audience of potential customers in search of high-quality, data-rich specimens​,” Ianelli explained.

Additionally, because these customers have already contracted with Scientist.com, the “source to settle” process is handled through that pre-existing agreement, he said.

"Human biospecimens are increasingly being used in drug research, so working with suppliers like ​iSpecimen on an ongoing basis supports our biopharma clients by ensuring their researchers access these materials in a manner compliant with both internal and external policies,​" Matt McLoughlin, senior director of compliance at Scientist.com told us.

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us

Products

View more

Webinars